Page last updated: 2024-11-07

penicillin g and Communicable Diseases, Emerging

penicillin g has been researched along with Communicable Diseases, Emerging in 5 studies

Penicillin G: A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission.
benzylpenicillin : A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.

Communicable Diseases, Emerging: Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.

Research Excerpts

ExcerptRelevanceReference
"Actinomycosis is a chronic granulomatous condition that commonly manifests as cervicofacial, pulmonary, or abdominal disease, caused by slowly progressive infection with oral and gastrointestinal commensal Actinomyces species."1.35Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. ( Beovic, B; Blanche, S; Brousse, N; Galmiche, L; Güngör, T; Holland, SM; Kayal, S; Lopatin, U; Mahlaoui, N; Reichenbach, J; Seger, RA; Siler, U; Zbinden, R, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobs, MR1
Good, CE1
Windau, AR1
Bajaksouzian, S1
Biek, D1
Critchley, IA1
Sader, HS1
Jones, RN1
Sim, MY1
Sia, CH1
Chew, KL1
Lum, LH1
Loh, PH1
Tambyah, PA1
Reichenbach, J1
Lopatin, U1
Mahlaoui, N1
Beovic, B1
Siler, U1
Zbinden, R1
Seger, RA1
Galmiche, L1
Brousse, N1
Kayal, S1
Güngör, T1
Blanche, S1
Holland, SM1
Sertour, N1
Menouard, M1
Poveda, JD1
Perra, A1
Baranton, G1
Postic, D1
Pan, SC1
Wang, JT1
Hsueh, PR1
Chang, SC1

Other Studies

5 other studies available for penicillin g and Communicable Diseases, Emerging

ArticleYear
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance

2010
Group B streptococcus bacteraemia and purulent pericarditis in an immunocompetent adult.
    QJM : monthly journal of the Association of Physicians, 2019, Oct-01, Volume: 112, Issue:10

    Topics: Anti-Bacterial Agents; Bacteremia; Communicable Diseases, Emerging; Drug Administration Schedule; Fe

2019
Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Dec-01, Volume: 49, Issue:11

    Topics: Actinomyces; Actinomycosis; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bon

2009
Cluster of leptospirosis cases among children in France.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:7

    Topics: Adolescent; Child; Communicable Diseases, Emerging; Disease Outbreaks; Female; France; Humans; Lepto

2002
Endocarditis caused by Propionibacterium acnes: an easily ignored pathogen.
    The Journal of infection, 2005, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Cefoxitin; Clindamycin; Communicable Diseases, Emerging; Endocarditis, Bacter

2005